All stock lists
Seaport Therapeutics, Inc. (NASDAQ:SPTX)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
20.96+0.76 (+3.76%)
Market cap
$1.12B
Insider Score
Health Score
Analyst consensus
Listed since
May 1, 2026
Website
Insider Score
84/ 100
SPTX Insider Score
Bullish1 qualifying trade · 1 insider · $99.33K bought in the last 90 days
Financial Health Score
Fair
From SPTX’s reported statements · FY2025 · 3 of 5 pillars
Profitability—
No revenue reported, so there is no margin to score.
- Revenue
- $0
- Net income
- -$74.9M
- Net margin
- —
Leverage—
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $5.1M
- Cash
- $46.0M
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $223.2M
- Current liabilities
- $12.8M
- Current ratio
- 17.46
Cash generation3 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$77.9M
- Free cash flow
- -$78.3M
Dilution & runway1 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 38.6M
- Share growth (1y)
- —
- Cash runway
- 7 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
SPTX Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 |
|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 |
| Revenue | 0.00 | 0.00 | 0.00 |
| Revenue Growth (YoY) | — | — | — |
| Cost of Revenue | 358.00 K | 351.00 K | 0.00 |
| Gross Profit | -358.00 K | -351.00 K | 0.00 |
| SG&A Expense | 6.45 M | 40.84 M | 6.11 M |
| R&D Expense | 23.89 M | 24.62 M | 21.43 M |
| Operating Expenses | 29.99 M | 65.46 M | 27.54 M |
| Operating Income | -30.34 M | -65.81 M | -27.54 M |
| Pretax Income | -26.43 M | -62.59 M | -24.89 M |
| Tax Provision | -38.00 K | 15.00 K | 519.00 K |
| Net Income | -26.39 M | -62.60 M | -25.41 M |
| EPS (Basic) | -0.49 | -1.17 | -0.48 |
| EPS (Diluted) | -0.49 | -1.17 | -0.48 |
| Shares Outstanding | 53.53 M | 53.53 M | 53.03 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.